Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RiVa: Rituximab and Varlilumab in B-cell Malignancies
NCT03307746Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Nov 2017
- Primary completion
- Feb 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of varlilumab in B cell lymphoma, sponsored by University Hospital Southampton NHS Foundation Trust. Started Nov 2017; status: completed.
02
Drugs
varlilumab
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT03307746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307746.